Trade Faron Pharmaceuticals Oy - FARN CFD
What is Faron Pharmaceuticals Oy (FARN)?
Faron Pharmaceuticals Oy is a biotechnology company focused on the development of innovative therapies for acute and life-threatening conditions. The company's research and development efforts concentrate on immunomodulatory and vascular-targeting treatments aimed at improving patient outcomes in areas such as cancer, organ transplantation, and acute respiratory distress syndrome. Faron Pharmaceuticals employs advanced scientific methodologies and clinical trial programs to advance its pipeline products through regulatory approval processes. The company collaborates with academic institutions and industry partners to enhance its research capabilities. It operates within the pharmaceutical and biotechnology sectors, adhering to stringent regulatory standards for drug development and safety. Faron Pharmaceuticals' strategic objective is to address unmet medical needs by delivering novel therapeutic solutions based on scientific innovation.
Faron Pharmaceuticals Oy Stock Price Today: Live Overview
The price today is shaped by current session dynamics with Hargreaves Services PLC priced at £0.4905. Its trading range today spans from £0.539 to £0.719, showing a change of 0% on the day.
FAQ: Faron Pharmaceuticals Oy (FARN)
What is the current price of FARN stock?
The current price is £0.4905.
Does FARN pay dividends?
Faron Pharmaceuticals Oy does not currently pay dividends.
Does FARN have a formal corporate presence or regional headquarters in the UAE?
Faron Pharmaceuticals Oy does not have an official regional office or subsidiary in the UAE and operates through distributors.
What is FARN best known for?
Faron Pharmaceuticals Oy is most famous for its development of immuno-oncology therapies.
What assets are typically shown together with FARN?
Commonly shown alongside FARN: Orezone Gold Corporation, Goosehead Insurance Inc, Sabre Corporation
Latest shares articles



